These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16281458)

  • 21. Reward ignorant modeling of dynamic treatment regimes.
    Wallace MP; Moodie EEM; Stephens DA
    Biom J; 2018 Sep; 60(5):991-1002. PubMed ID: 29845644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpretable Dynamic Treatment Regimes.
    Zhang Y; Laber EB; Davidian M; Tsiatis AA
    J Am Stat Assoc; 2018; 113(524):1541-1549. PubMed ID: 30774169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer.
    Wang L; Rotnitzky A; Lin X; Millikan RE; Thall PF
    J Am Stat Assoc; 2012 Jun; 107(498):493-508. PubMed ID: 22956855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Start-up designs for response-adaptive randomization procedures with sequential estimation.
    Haines LM; Sadiq H
    Stat Med; 2015 Sep; 34(21):2958-70. PubMed ID: 25944171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Power analysis in a SMART design: sample size estimation for determining the best embedded dynamic treatment regime.
    Artman WJ; Nahum-Shani I; Wu T; Mckay JR; Ertefaie A
    Biostatistics; 2020 Jul; 21(3):432-448. PubMed ID: 30380020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imputation-based Q-learning for optimizing dynamic treatment regimes with right-censored survival outcome.
    Lyu L; Cheng Y; Wahed AS
    Biometrics; 2023 Dec; 79(4):3676-3689. PubMed ID: 37129942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Bayesian inference and dynamic treatment regimes.
    Saarela O; Arjas E; Stephens DA; Moodie EE
    Biom J; 2015 Nov; 57(6):941-58. PubMed ID: 26259996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating tree-based dynamic treatment regimes using observational data with restricted treatment sequences.
    Zhou N; Wang L; Almirall D
    Biometrics; 2023 Sep; 79(3):2260-2271. PubMed ID: 36063542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inference about the expected performance of a data-driven dynamic treatment regime.
    Chakraborty B; Laber EB; Zhao YQ
    Clin Trials; 2014 Aug; 11(4):408-417. PubMed ID: 24925083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptive contrast weighted learning for multi-stage multi-treatment decision-making.
    Tao Y; Wang L
    Biometrics; 2017 Mar; 73(1):145-155. PubMed ID: 27213913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Causal inference from longitudinal studies with baseline randomization.
    Toh S; Hernán MA
    Int J Biostat; 2008 Oct; 4(1):Article 22. PubMed ID: 20231914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inference for non-regular parameters in optimal dynamic treatment regimes.
    Chakraborty B; Murphy S; Strecher V
    Stat Methods Med Res; 2010 Jun; 19(3):317-43. PubMed ID: 19608604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity analysis for subsequent treatments in confirmatory oncology clinical trials: A two-stage stochastic dynamic treatment regime approach.
    Hagiwara Y; Shinozaki T; Mukai H; Matsuyama Y
    Biometrics; 2021 Jun; 77(2):702-714. PubMed ID: 32420624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential monitoring of randomization tests: stratified randomization.
    Zhang Y; Rosenberger WF; Smythe RT
    Biometrics; 2007 Sep; 63(3):865-72. PubMed ID: 17825016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Semiparametric Bayesian inference for optimal dynamic treatment regimes via dynamic marginal structural models.
    Rodriguez Duque D; Stephens DA; Moodie EEM; Klein MB
    Biostatistics; 2023 Jul; 24(3):708-727. PubMed ID: 35385100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Q-learning residual analysis: application to the effectiveness of sequences of antipsychotic medications for patients with schizophrenia.
    Ertefaie A; Shortreed S; Chakraborty B
    Stat Med; 2016 Jun; 35(13):2221-34. PubMed ID: 26750518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maximizing power and minimizing treatment failures in clinical trials.
    Rosenberger WF; Huc F
    Clin Trials; 2004; 1(2):141-7. PubMed ID: 16281886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Joint modeling and multiple comparisons with the best of data from a SMART with survival outcomes.
    Chao YC; Tran Q; Tsodikov A; Kidwell KM
    Biostatistics; 2022 Jan; 23(1):294-313. PubMed ID: 32659784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.